Gianfranco Nazzi — Executive Vice President of Growth Markets Commercial at Teva Pharmaceutical Industries Limited

Mr. Gianfranco Nazzi has been an Executive Vice President of Growth Markets Commercial at Teva Pharmaceutical Industries Limited since November 27, 2017. Mr. Nazzi served as President and Chief Executive Officer of Growth Markets at Global Generic Medicines Group since March 2017. Mr. Nazzi served as President and Chief Executive Officer of Growth Markets at the Global Generic Medicines group. Prior to that, he served as Senior Vice President of Specialty Medicines Europe at Generic Medicines. Mr. Nazzi joined Teva as Senior Vice President of Specialty Medicines Europe in 2014. Prior to joining Teva, he served 7 years at AstraZeneca in various senior roles, including Sales and Marketing Vice President Europe, Global Vice President of Respiratory, General Manager of the Balkans and Vice President Primary Care in Italy. At GlaxoSmithKline, he served for two years as BU Director Metabolic & Cardiovascular and at Eli Lilly and Company he served for 5 years in various sales and marketing roles in both Italy and the US. He began his career at Danieli. Mr. Nazzi received his BA degree in economics from the University of Udine and his Masters degree in Management Studies from SDA Bocconi.